TNF and rheumatoid arthritis: The two proinflammatory cytokines, TNF and IL-6, are therapeutic targets for the treatment of RA (Smolen and Aletaha, 2015), whereas inhibition of IL-1 using biological therapies has not been effective in preventing RA (McInnes et al., 2016).